Improvements in Skin and Nail Psoriasis are Positively Correlated across Systemic Psoriasis Therapies
Journal Title: Journal of Dermatology Research - Year 2023, Vol 4, Issue 2
Abstract
Objective: For clinical scenarios where patients have moderate to severe psoriasis and nail psoriasis, knowing whether skin response is correlated with nail response would provide insight into the relationship between psoriatic skin and nail unit inflammation. The primary objective of this study was to determine if improvement in skin and nail psoriasis across a range of systemic therapies are correlated. Methods: Relevant publications pertaining to systemic therapies approved in the US for psoriasis were identified via PubMed search. Only studies with placebo controls were included. The paired point estimates of the PASI 75 response treatment effect [i.e., the placebo-adjusted PASI 75 response rate] (independent variable) and mean percentage NAPSI improvement for target fingernail treatment effect [also placebo-adjusted] (dependent variable) were calculated for each therapy. Simple linear regression analysis weighted by the standard errors for the independent and dependent variables was performed. Results: Ten paired treatment effects for 4 systemic therapies (apremilast, adalimumab, etanercept, and guselkumab) were obtained. Guselkumab and adalimumab were associated with the greatest nail improvement, and guselkumab was associated with the greatest skin response rate. PASI 75 response rate and mean percentage improvement target fingernail NAPSI were positively correlated (p=0.03), with an R2 value of 0.48. Conclusions: There is significant positive correlation across different therapies between the magnitude of improvement in psoriatic skin and nail disease among patients with moderate-severe psoriasis and clinically significant nail disease.
Authors and Affiliations
Thomas SD Okun, Martin M Okun
Keywords
Related Articles
- EP ID EP717027
- DOI https://doi.org/10.46889/JDR.2023.4203
- Views 60
- Downloads 0
Diagnosis of HyperIgE Syndromes (HIES) on Black Phenotype Patients with Atopic Dermatitis Followed in Dakar, Senegal
This study aimed to determine the epidemiological and clinical-biological manifestation of hyper IgE syndromes during atopic dermatitis in the pediatric dermatology department of the Centre Hospitalier National d’Enfants...
Recent Highlights and Expert Opinion on Psoriasis Management
Psoriasis is a common chronic inflammatory skin disorder characterized by red, flaky, crusty, scaly, itchy, thickened plaques (Fig. 1), which affects approximately 2% of the population worldwide [1-2]. Increasing evide...
Erythema Nodosum Associated with Terbinafine Therapy- A Case Report
Terbinafine is a commonly used anti-fungal agent in dermatological practice but not one clearly associated with erythema nodosum. There is only one published report in 2014 that described a delayed onset of erythema nodo...
A Naevus Sebaceous with Tumour of the Follicular Infundibulum, Trichilemmoma, Desmoplastic Trichilemmoma, Apocrine Adenoma and Syringocystadenoma Papilliferum: Report of a Case
Nevus Sebaceous of Jadasson (SNJ) has been reported with various coexisting benign and rarely with malignant neoplasms. We present a case of SNJ with five benign epidermal and adnexal neoplasms, some of them with unusu...
Human Protothecosis: Case Report of a Rare Algal Infection
Protothecosis: is a rare disease caused by opportunistic algae infection of the genus Prototheca. An 84-year-old female patient has presented with an erythematous, infiltrated, papulopustular plaque with areas of central...